Evidence map›Paper›PMID 37125253›Full record

ArticleJGH open : an open access journal of gastroenterology and hepatology2023

Prevalence of small intestinal bacterial overgrowth in irritable bowel syndrome (IBS): Correlating H

Philippe Onana Ndong, Hanae Boutallaka, Eugenia Marine-Barjoan, Dann Ouizeman, Raja Mroue, Rodolphe Anty, Geoffroy Vanbiervliet, Thierry Piche

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in JGH open : an open access journal of gastroenterology and hepatology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05915767 (Assessment of Therapeutic Effect of Olive), which is not on this map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05915767 nacompletednot on this map

Assessment of Therapeutic Effect of Olive (Olea Europaea L.) Leaf Tea on Gastrointestinal Symptoms and Body Composition in Adults With Small Intestinal Bacterial Overgrowth

TypeinterventionalSponsorUniversity of Veterinary and Animal Sciences, Lahore - PakistanRan2023 to 2023Enrolled50ConditionsSmall Intestinal Bacterial Overgrowth, Gastrointestinal Disorder, FunctionalArmsOlive leaf tea
3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Review
  3. Therapeutic effects of olive leaf tea (Frontiers in nutrition · 2025
    Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Philippe Onana NdongGastro-entérologie, Hôpital L'Archet 2 Centre Hospitalier Universitaire de Nice Nice France.ORCID https://orcid.org/0000-0002-4859-5619
Hanae BoutallakaGastro-entérologie, Hôpital L'Archet 2 Centre Hospitalier Universitaire de Nice Nice France.
Eugenia Marine-BarjoanGastro-entérologie, Hôpital L'Archet 2 Centre Hospitalier Universitaire de Nice Nice France.
Dann OuizemanGastro-entérologie, Hôpital L'Archet 2 Centre Hospitalier Universitaire de Nice Nice France.
Raja MroueGastro-entérologie, Hôpital L'Archet 2 Centre Hospitalier Universitaire de Nice Nice France.
Rodolphe AntyGastro-entérologie, Hôpital L'Archet 2 Centre Hospitalier Universitaire de Nice Nice France.ORCID https://orcid.org/0000-0001-8194-9805
Geoffroy VanbiervlietGastro-entérologie, Hôpital L'Archet 2 Centre Hospitalier Universitaire de Nice Nice France.
Thierry PicheGastro-entérologie, Hôpital L'Archet 2 Centre Hospitalier Universitaire de Nice Nice France.
Centre Hospitalier Universitaire de Nice · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Aim: The prevalence and the role of small intestinal bacterial overgrowth (SIBO) in irritable bowel syndrome (IBS) remain unclear, as the literature provides heterogeneous information on the subject. The aim of this study was to determine the prevalence of SIBO in IBS and to assess the correlation between methane and hydrogen levels measured during breath tests and the severity of IBS. Method: Two-hundred and forty-seven patients with IBS were prospectively included. A glucose breath test (GBT) measured H Results: The prevalence of SIBO in IBS was 36.4% (9.7% with H Conclusion: SIBO has a high prevalence in IBS but does not increase its severity. Individual susceptibility to pain may have a greater influence on the severity of IBS.

Indexed as

gastrointestinal disordersglucose breath testhydrogenirritable bowel syndromemethanesmall intestinal bacterial overgrowth

Identifiers

PMID37125253
PMCPMC10134763
OpenAlexW4362581962

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.